Humana (HUM) is a publicly traded Healthcare sector company. As of May 20, 2026, HUM trades at $307.98 with a market cap of $36.74B and a P/E ratio of 32.86. HUM moved -1.34% today. Year to date, HUM is +17.42%; over the trailing twelve months it is +25.56%. Its 52-week range spans $163.11 to $324.38. Analyst consensus is neutral with an average price target of $241.18. Rallies surfaces HUM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes HUM SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $307.98 |
| Market Cap | $36.74B |
| P/E Ratio | 32.86 |
| EPS | $9.39 |
| Dividend Yield | 0.89% |
| 52-Week High | $324.38 |
| 52-Week Low | $163.11 |
| Volume | 589.38K |
| Avg Volume | 0 |
| Revenue (TTM) | $137.20B |
| Net Income | $1.15B |
| Gross Margin | 0.00% |
20 analysts cover HUM: 0 strong buy, 6 buy, 12 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $241.18.